Pharmaceuticals

Invest Ontario was at BIO 2023 to promote the province’s growing life sciences and biotech sector and explore new opportunities for investment.

Senior Economic Officers Aaron Pinto and Chelsea Peet discuss Ontario’s key life sciences value propositions and what makes the province a leader in the sector.

Ontario has long been an attractive jurisdiction for high-quality clinical trials, but within the last decade, its activity outranks other global jurisdictions.

The Ontario government has concluded a successful trade mission to India to strengthen relationships with economic partners and attract new investments in key sectors.

Some of the world’s most innovative medicines can be traced back to the labs and manufacturing facilities of Dalton Pharma Services.

Treadwell has adopted a global growth strategy but remains committed to Toronto, Ontario, where its innovations first took shape.

Ontario is home to a thriving biotechnology sector, with an abundance of top institutions, researchers, developers and manufacturers.

When the pandemic hit, catching the world off guard and causing drug manufacturers to scramble, Novocol Pharma president, Atif Zia, thought to himself, I know we can be more helpful.

When Roche Canada colleagues saw the opportunity to establish a centre of excellence (CoE) for artificial intelligence, they knew the best home would be in Canada.

Takeda’s culture of sharing their expertise and heft as a global pharma leader with cutting-edge innovators has one overarching goal: to improve the quality of life for patients worldwide by developing and delivering life-changing treatments.